Latest News & Innovations: IBA Dosimetry

IBA reports Half Year 2026 results, on track with its improved profitability trajectory

Louvain-la-Neuve, Belgium, 27 August 2026 - IBA (Ion Beam Applications S.A.), today announces its consolidated results for the first half of 2026, with performance on track with FY…

ECMP 2026: See How IMED Hospital Optimizes QA Workflows in Clinical Practice

Register now to secure your seat!

Meet IBA Dosimetry at 6th ECMP 2026

See us at Booth #18 and learn about our latest innovations for your QA requirements.

Meet IBA Dosimetry at ASTRO 2026

Discover the latest advances in radiotherapy QA at Booth #843.

Master the Essentials: Commissioning and Small Field Dosimetry

Master the Essentials: Commissioning & Small Field Dosimetry

IBA reports solid Full Year 2024 results

Louvain-la-Neuve, Belgium, 20 March 2025 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the…

IBA launches myQA Blue Phantom³ for radiation therapy quality assurance

Fastest automatic levelling offering on the market

Seamless integration with all linear accelerators

IBA launches QUASAR® GRID3D Advantage Image Distortion Analysis System

New standard in the Quality Assurance of image distortion for MR guided radiation therapy and MR simulation in planning

IBA Business Update Q1 2025

Year starting on track

Louvain-la-Neuve, Belgium, 22 May 2025 - IBA (Ion Beam Applications S.A), the world leader in

particle accelerator technology, today announces its…

IBA reports strong Half Year 2025 results, transforming towards a more profitable business

Louvain-la-Neuve, Belgium, 28 August 2025 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the…